Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy
CONCLUSIONS: The perioperative use of anti-VEGF reduces the risk of late POVCH, probably results in lower early POVCH risk and may improve visual outcomes. It also reduces the incidence of intraoperative retinal breaks. The evidence is very uncertain about its effect on the need for silicone oil tamponade. The reported complications from its use appear to be low. Agreement on variables included and outcome standardisation is required in trials studying vitrectomy for PDR.PMID:37260074 | PMC:PMC10230853 | DOI:10.1002/14651858.CD008214.pub4
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Panagiotis Dervenis Nikolaos Dervenis Jonathan M Smith David Hw Steel Source Type: research
More News: Bleeding | Brazil Health | Canada Health | China Health | Databases & Libraries | Diabetes | Egypt Health | Endocrinology | Eyes | General Medicine | Indonesia Health | Iran Health | Italy Health | Japan Health | Mexico Health | Middle East Health | Pakistan Health | South Korea Health | Study | Vitamin A